Current Value of Holding

$15.9 Million

Shares

266 Thousand

% of Portfolio

0.05%

Average Buy Price

$79.4

Avg closing price
Price range

33 Steven Cohen Biomarin Pharmaceutical - Registered Shares Trades

Steven Cohen acquired 266 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $15.9 Million. That's 0.05% of their equity portfolio (383rd largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q2 2014. Since then Steven Cohen bought shares twenty more times and sold shares on eighteen occasions. The investor's estimated purchase price is $21.1 Million, resulting in a loss of 25%.

Avg closing price
Price range
Increased shares by 34.8% (+68.7 Thousand shares) Q4 2024
Avg closing price $66.95
Price range $61.93 - $70.53
New holding (+198 Thousand shares) Q3 2024
Avg closing price $83.67
Price range $69.02 - $93.84
Sold -1.35 Million shares Q2 2024
Avg closing price $83.25
Price range $74.43 - $92.22
Increased shares by 195.6% (+890 Thousand shares) Q1 2024
Avg closing price $89.52
Price range $83.81 - $99.00
New holding (+455 Thousand shares) Q4 2023
Avg closing price $88.47
Price range $76.22 - $98.51
Sold -717 Thousand shares Q1 2023
Avg closing price $103.67
Price range $87.74 - $117.27
Increased shares by 20.4% (+121 Thousand shares) Q4 2022
Avg closing price $93.88
Price range $80.93 - $108.63
Increased shares by 302.6% (+448 Thousand shares) Q3 2022
Avg closing price $89.04
Price range $82.16 - $96.94
Sold 59.7% shares (-219 Thousand shares) Q2 2022
Avg closing price $79.62
Price range $71.48 - $86.85
Sold 55.4% shares (-455 Thousand shares) Q1 2022
Avg closing price $83.67
Price range $74.28 - $92.69
Increased shares by 3.8% (+30 Thousand shares) Q4 2021
Avg closing price $82.51
Price range $71.72 - $91.47
Increased shares by 116.0% (+425 Thousand shares) Q3 2021
Avg closing price $78.90
Price range $74.77 - $85.47
Increased shares by 42.9% (+110 Thousand shares) Q2 2021
Avg closing price $79.27
Price range $75.51 - $84.79
Sold 32.7% shares (-125 Thousand shares) Q1 2021
Avg closing price $81.69
Price range $74.73 - $90.69
Sold 59.6% shares (-563 Thousand shares) Q4 2020
Avg closing price $79.28
Price range $72.61 - $90.20
New holding (+944 Thousand shares) Q3 2020
Avg closing price $101.18
Price range $71.87 - $131.03
Sold -261 Thousand shares Q1 2020
Avg closing price $86.16
Price range $71.37 - $96.85
Increased shares by 303.1% (+196 Thousand shares) Q4 2019
Avg closing price $75.53
Price range $64.27 - $86.37
Sold 74.3% shares (-187 Thousand shares) Q3 2019
Avg closing price $77.02
Price range $67.40 - $85.11
New holding (+252 Thousand shares) Q2 2019
Avg closing price $85.55
Price range $80.35 - $93.90

News about Biomarin Pharmaceutical Inc. - Registered Shares and Steven Cohen

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!